{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-007902","form_type":"8-K","ticker":"PAVM","cik":"0001624326","company_name":"PAVmed Inc.","filed_at":"2025-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.224740+00:00","generated_at":"2026-05-26T06:56:18.233471+00:00","sec_items":["3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"PAVmed raises $2.37M via PIPE of common stock and pre-funded warrants with Veris subsidiary shares","bullets":["Sale of 2,574,350 shares and 756,734 pre-funded warrants at $0.7115/unit; Veris issues 677,143 shares to investors.","Gross proceeds of $2.37M; proceeds to fund Veris' implantable physiological monitor and working capital.","Company grants anti-dilution protection via additional Veris shares; restricts indebtedness until Aug 18, 2026.","Registration rights granted; stockholder vote required for warrant shares by June 30, 2025.","Transaction exempt under Section 4(a)(2) and Regulation D; no public offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-007902","json":"https://secwatch.observer/filing/0001493152-25-007902.json","markdown":"https://secwatch.observer/filing/0001493152-25-007902.md","text":"https://secwatch.observer/filing/0001493152-25-007902.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1624326/000149315225007902/0001493152-25-007902-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1624326/000149315225007902/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T06:56:18.233471+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}